Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FDX | DB |
|---|---|---|
| Price | $280.39 | $35.57 |
| Change today | ▼ 3.81% | ▼ 0.85% |
| Market cap | $66.36B | $66.83B |
| Return, 3 months | -11.5% | +4.6% |
| Return, year to date | +21.5% | -4.4% |
| Return, 1 year | +50.9% | +2.5% |
| P/E (TTM) | 15.1 | 10.4 |
| P/B | 2.1 | 0.9 |
| P/E percentile vs own 5y | 71st | 81st |
| Dividend yield | 2.07% | 3.21% |
| Revenue growth (YoY, latest qtr) | +12.5% | +8.4% |
| Net profit growth (YoY) | -3.1% | +9.9% |
| Gross margin | 21.8% | – |
| Operating margin | 7.0% | – |
| Net margin | 4.7% | 19.7% |
| Return on equity | 14.8% | 8.3% |
| Analyst target vs. price | +28.6% | +23.6% |
| Analyst buy share | 89% | 78% |
| RSI (14) | 31 | 34 |
| 30-day volatility | 24.5% | 25.1% |
| Max drawdown, 1 year | -13.6% | -29.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.